About Index Trending news
Analyze
Pricing
Amgen Inc.

Amgen Inc.

Amgen Inc.

Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

07 Sep 2017
$240,000,000
Venture capital (Series B)

WuXi NextCODE racks up $240 mln Series B

PE Hub
+1
23 Aug 2017
$6,000,000
Venture capital (Series C)

GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech

Xconomy
+1
25 Apr 2017
$29,000,000
Venture capital (Series C)

GV joins $29 million investment into Science 37 to bring clinical trials to the home

VentureBeat
+1
20 Jul 2016
$11,900,000
Venture capital (Series B)

Amgen and Merck KGaA Invest in Bostons Akili Increasing Funding Round to 42 4 Million

biospace
+1
07 Jan 2016
$29,500,000
Venture capital (Series D)
Polaris Partners, OrbiMed, Topspin Partners, +6

Alector Raises $29.5M in Series D Financing

FinSMEs
18 Feb 2015
$8,500,000
Venture capital (Series C)
Atlas Venture, Boulder Ventures, Broadview Ventures, +2